Published in
Oxford University Press, The Oncologist, 5(26), p. e905-e906, 2021
DOI: 10.1002/onco.13736
Links
Tools
Temporal Trends and Predictors in the Use of Stereotactic Body Radiotherapy for Treatment of Metastatic Renal Cell Carcinoma in the U.S
Journal article published in 2021 by
Marco Paciotti,
Andrew L. Schmidt 
,
Praful Ravi,
Rana R. McKay,
Quoc-Dien Trinh,
Toni K. Choueiri
,
Praful Ravi,
Rana R. McKay,
Quoc-Dien Trinh,
Toni K. Choueiri
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
This letter to the editor outlines the use of stereotactic body radiotherapy for metastatic renal cell carcinoma in the U.S., identifying clinical predictors of utilization using the National Cancer Database.